list all glp 1 drugs GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom What to Know About GLP-1s
Description
These data align with an integrated analysis of 36 clinical studies that affirmed cardiovascular safety with up to 4-years treatment with either DPP-4 inhibitors or GLP-1R agonists [655]
Animal studies suggest that GLP-1RAs may reduce the intake of addictive substances, such as alcohol and drugs [20]
A lower urine albumin/creatinine ratio has been reported with liraglutide (3.0 mg) in patients with type 2 diabetes [14]
Because Retatrutide is a sophisticated 39-amino-acid triple receptor agonist, researchers should approach it with the same level of care given to other sensitive laboratory biomolecules
References 1 VaduganathanMMensahGATurcoJVFusterVRothGA
It is administered subcutaneously (under the skin) once daily and can be taken alongside insulin or other diabetes medications
